Latest News
Analyst
NASDAQ
NYSE
Blog
Canada
Europe
AUS

Sign in

Welcome!Log into your account

your username

your password

Forgot your password?

Password recovery

Recover your password

your email

Search

Sign in

Welcome! Log into your account

your username

your password

Forgot your password? Get help

Password recovery

Recover your password

your email

A password will be e-mailed to you.

Friday, January 28, 2022

About us
Disclaimer
Contact
Privacy Policy
Our Team

Advertisement:

Latest News
Analyst
- Analyst
  
  Silk Road Medical (NASDAQ:SILK) Downgraded by Zacks Investment Research to Hold
  
  2021-10-31
  
  Analyst
  
  Sleep Number (NASDAQ:SNBR) Upgraded by Zacks Investment Research to Hold
  
  2021-10-31
  
  Analyst
  
  South Plains Financial (NASDAQ:SPFI) Upgraded by Zacks Investment Research to Buy
  
  2021-10-31
  
  Analyst
  
  SP Plus (NASDAQ:SP) Upgraded by Zacks Investment Research to Buy
  
  2021-10-31
  
  Analyst
  
  State Auto Financial (NASDAQ:STFC) Downgraded by Zacks Investment Research to Sell
  
  2021-10-31
NASDAQ
NYSE
Blog
Canada
Europe
AUS

facebook
twitter
googleplus
pinterest
dribbble
instagram
flickr
linkedin

Home Tags Lantern Pharma

Tag: Lantern Pharma

Factors Likely to Have Influenced Earnings Results Lantern Pharma (NASDAQ:LTRN)

mastockdipradhe - 2021-10-29 0

Did they just beat EPS? Lantern Pharma (NASDAQ:LTRN)

mastockdipradhe - 2021-03-10 0

Earnings Report: Here’s what to expect from Lantern Pharma (NASDAQ:LTRN)

mastockdipradhe - 2021-03-04 0

Must-See Earnings Estimates for: Lantern Pharma (NASDAQ:LTRN)

mastockdipradhe - 2021-02-25 0

thoughts on these estimates, before EPS results? Lantern Pharma (NASDAQ:LTRN)

mastockdipradhe - 2021-02-18 0

Analyst Valuation and EPS Growth for Lantern Pharma (NASDAQ:LTRN)

mastockdipradhe - 2021-02-11 0

Does Earnings Surprise History Hold Any Clue for Lantern Pharma (NASDAQ:LTRN)

mastockdipradhe - 2020-10-29 0

Stock Market Daily is your financial news portal. Analyst reports, analyst insights, earnings report, Daily upgrade and downgrade and much much more for better investment knowledge.

Editor Picks

Silk Road Medical (NASDAQ:SILK) Downgraded by Zacks Investment Research to Hold

Analyst 2021-10-31

Sleep Number (NASDAQ:SNBR) Upgraded by Zacks Investment Research to Hold

Analyst 2021-10-31

South Plains Financial (NASDAQ:SPFI) Upgraded by Zacks Investment Research to Buy

Analyst 2021-10-31

Latest News

Will stock surge before Earnings results? Orchard Therapeutics (NASDAQ:ORTX)

NASDAQ 2021-11-01

Confused? Buy or Sell in volatile market – Analyst report DURECT (NASDAQ:DRRX)

NASDAQ 2021-11-01

Wall street estimates Earnings report Eneti (NASDAQ:NETI)

NASDAQ 2021-11-01

Popular Categories

USA-124236
Analyst1539
NASDAQ100
NYSE50
Blog12
AUS0
Canada0
Europe0

© Newspaper WordPress Theme by TagDiv

About us
Disclaimer
Contact
Privacy Policy
Our Team

Posting....

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Powered by GDPR Cookie Compliance

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.